PATENT CLAIM ANALYSIS

Application Number: 16325610
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["435", "232000"]

Abstract:
Provided herein is a genetically modified host cell comprising a heterologous nucleic acid encoding a biofilm dispersal polypeptide that decreases intracellular c-di-GMP levels and enhances the production of lysine and lysine derivatives. Further provided are methods of generating such cell and producing lysine and lysine derivatives using the genetically modified host cell.

Claim (Index 24):
The method of any one of  claims 21  to  23 , wherein the heterologous nucleic acid encoding the biofilm dispersal polypeptide is encoded by an expression vector introduced into the cell, wherein the expression vector comprises the heterologous nucleic acid operably linked to a promoter.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.45946
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15774820', '15517633', '12772538', '12993399', '09722441']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.604829781619188
- 35 USC 102 Novelty (BERT): 0.5648118243025575
- Combined Prediction Score: 0.600827985887525
- Mean Citation Score: 317.812236
- Max Citation Score: 459.55585
- Similarity Product: 333.6264585164726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test